Search and analyze individual stocks with comprehensive metrics
Nexus Surgical
Fundamental Score
Nexus Surgical Share Price & Market Analysis
Profitability Metrics
Return on Equity
Return on Capital Employed
Operating Profit Margin (5Y)
Dividend Yield
Valuation Metrics
Price to Earnings
Market Capitalization
Industry P/E
Growth Metrics
YoY Quarterly Profit Growth
YoY Quarterly Sales Growth
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Financial Health
Debt to Equity
Interest Coverage
Free Cash Flow (5Y)
Ownership Structure
Promoter Holding
FII Holding
DII Holding
Pledged Percentage
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Market Data Analysis & Educational Insights
Educational evaluation of NEXUSSURGL across key market metrics for learning purposes.
Positive Indicators
9 factors identified
Strong Return on Equity (61.73%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (83.95%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance. This indicates quality business fundamentals.
Attractive Valuation (P/E: 17.59 vs Industry: 34.35)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity if fundamentals support the business case.
Robust Profit Growth (66.67%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture. This suggests positive business trajectory.
Consistent Growth Track Record (27.02% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model and market opportunity execution over time.
Excellent EPS Growth (75.54% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential and effective capital allocation over extended periods.
Strong Profit Growth Track Record (75.54% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model and effective operational leverage over time.
Debt-Free Balance Sheet (D/E: 0.00)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns and flexibility for growth investments.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral, reducing forced-selling risk.
Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.
Risk Factors
3 factors identified
Low Promoter Commitment (18.73%)
Observation: Reduced promoter stake may indicate limited confidence.
Analysis: Low promoter holding may raise questions about management commitment and long-term vision alignment.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints. Assess capital allocation strategy.
Small Market Cap
Observation: Higher investment risk due to limited size.
Analysis: Small-cap stocks typically carry higher volatility and liquidity risks.
📊 Educational Market Overview
Disclaimer: The ratings and scores are generated algorithmically from publicly available market data and are provided for educational and informational purposes only. They do not constitute investment advice, recommendation, or solicitation to buy/sell any securities.
Loading Peer Comparison
Finding companies in the Other Financial Services sector...
Financial Statements
Comprehensive financial data for Nexus Surgical
About NEXUSSURGL
Company Details
Market Information
Performance
NEXUSSURGL Stock Details & Analysis
Key Financial Metrics
Growth & Valuation
Frequently Asked Questions
What is the current price of NEXUSSURGL?
NEXUSSURGL is currently trading at ₹16.72 with a gain of 0.00% today. The current market price (CMP) represents the last traded price of NEXUSSURGL shares on the stock exchange. This price fluctuates throughout trading hours based on supply and demand. You can track real-time price movements, percentage changes, and trading volume in the header section.
What is the P/E ratio of NEXUSSURGL and what does it mean?
NEXUSSURGL has a P/E ratio of 17.59x compared to the industry average of 34.35x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹18 for every ₹1 of annual earnings. This is lower than the industry average, which might indicate undervaluation or slower growth expectations.
How is NEXUSSURGL performing according to Bull Run's analysis?
NEXUSSURGL has a Bull Run fundamental score of 56.8/100, which indicates moderate strength with some areas for improvement. This comprehensive rating is based on 15+ financial parameters including profitability (ROE: 61.73%), growth metrics, valuation ratios, and financial health indicators. The score updates quarterly with new financial data and helps you quickly assess overall investment quality.
What sector and industry does NEXUSSURGL belong to?
NEXUSSURGL operates in the Finance industry. This sector classification helps understand the broader economic trends, regulatory framework, and competitive landscape affecting Nexus Surgical. Companies in this industry typically face similar market dynamics, cyclical patterns, and macroeconomic factors. Understanding the industry context is crucial for peer comparison and assessing how sector-specific trends might impact the stock's performance.
What is Return on Equity (ROE) and why is it important for NEXUSSURGL?
NEXUSSURGL has an ROE of 61.73%, which indicates excellent management efficiency and profitable operations. Return on Equity measures how efficiently Nexus Surgical generates profits from shareholders' equity. An ROE of 62% means the company generates ₹62 profit for every ₹100 of shareholders' equity. This metric is crucial for assessing management's ability to create value for shareholders.
How is NEXUSSURGL's debt-to-equity ratio and what does it indicate?
NEXUSSURGL has a debt-to-equity ratio of 0.00, which indicates conservative financing with low financial risk. This means the company has ₹0 of debt for every ₹100 of equity. This conservative approach provides financial stability but may limit growth potential.
What is NEXUSSURGL's dividend yield and is it a good dividend stock?
NEXUSSURGL offers a dividend yield of 0.00%, which means you receive ₹0.00 annual dividend for every ₹100 invested. The focus appears to be more on growth rather than dividend income. Dividend yield is calculated as annual dividend per share ÷ current share price × 100. Evaluate dividend consistency over 5+ years and free cash flow coverage for sustainability.
How has NEXUSSURGL grown over the past 5 years?
NEXUSSURGL has achieved 5-year growth rates of: Sales Growth 27.02%, Profit Growth 75.54%, and EPS Growth 75.54%. This consistent double-digit growth indicates a strong business model and competitive positioning. Sales growth indicates market expansion, profit growth shows operational efficiency, and EPS growth directly impacts share price appreciation potential.
What is the promoter holding in NEXUSSURGL and why does it matter?
Promoters hold 18.73% of NEXUSSURGL shares, with 0.00% of promoter shares pledged. This promoter holding level suggests balanced ownership between management and public shareholders. Low pledging indicates financial stability of promoters. Recent change in promoter holding: 0.00%.
How does NEXUSSURGL compare with its industry peers?
NEXUSSURGL trades at P/E 17.59x vs industry average 34.35x, with ROE of 61.73% and ROCE of 83.95%. The stock appears undervalued relative to peers based on P/E ratio. Peer comparison helps identify whether NEXUSSURGL is outperforming its competitive set in profitability, growth, and valuation metrics.
What is NEXUSSURGL's market capitalization and what category does it fall into?
NEXUSSURGL has a market capitalization of ₹10 crores, making it a Small-cap stock. Small-cap stocks offer high growth potential but with higher volatility and risk. Market cap is calculated as current share price × total outstanding shares, representing the company's total market value.
What are the key financial ratios to consider for NEXUSSURGL?
Key ratios for NEXUSSURGL: ROE 61.73% (Excellent), ROCE 83.95%, P/E 17.59x, Debt-to-Equity 0.00, Interest Coverage N/Ax. These ratios help assess profitability (ROE, ROCE), valuation (P/E), financial health (D/E, Interest Coverage), and overall investment quality. Compare these with industry medians and historical trends for meaningful analysis.
How volatile is NEXUSSURGL stock and what is its beta?
NEXUSSURGL has a beta of N/A, which means it is less volatile than the market and offers defensive characteristics. Beta measures price volatility relative to the Nifty 50. Lower beta stocks provide stability during uncertain market conditions. Consider beta alongside your risk tolerance and portfolio diversification strategy.
What is the 52-week high and low for NEXUSSURGL?
NEXUSSURGL has a 52-week high of ₹N/A and low of ₹N/A. Currently trading at ₹16.72, the stock is within its annual trading range. Trading near highs indicates strong momentum but limited upside potential.
What are the key risks associated with investing in NEXUSSURGL?
Key risks for NEXUSSURGL include: Market volatility (Beta: N/A), financial leverage (Debt-to-Equity: 0.00), and operational challenges. The stock has a Fundamental Score of 56.8/100, indicating moderate risk requiring careful monitoring. Sector-specific risks in Finance include regulatory changes, economic cycles, and competitive pressures. Consider your risk tolerance, investment horizon, and portfolio diversification before investing. Past performance doesn't guarantee future results.
What is NEXUSSURGL's operating profit margin and how has it trended?
NEXUSSURGL has a 5-year average Operating Profit Margin (OPM) of 10.01%, which is good and shows decent operational efficiency. Operating Profit Margin shows operational efficiency by measuring operating profit as a percentage of revenue. Monitor margin trends to assess management's ability to control costs and improve efficiency. Compare with industry peers to understand relative performance.
How is NEXUSSURGL's quarterly performance in terms of sales and profit growth?
NEXUSSURGL's recent quarterly performance shows YoY Sales Growth of -1.70% and YoY Profit Growth of 66.67%. Growth rates indicate the current business trajectory and market demand. Sales growth shows market demand while profit growth reveals operational efficiency and margin management.
What is the FII and DII holding pattern in NEXUSSURGL?
NEXUSSURGL has FII holding of 0.00% and DII holding of 0.00%, totaling 0.00% institutional ownership. This institutional participation level shows the confidence of professional money managers. Monitor quarterly changes in institutional holdings for investment flow trends and sentiment.